Skip to main content
SpringerLink
Log in

Blockade von Immuncheckpoints auch in der Behandlung des Analkarzinoms sinnvoll

Nivolumab für das vorbehandelte metastasierte Analkarzinom

  • journal club
  • Published:
InFo Onkologie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

1

Literatur

  1. Morris VK et al. Lancet Oncol. 2017;18(4):446–53.

    Article  CAS  Google Scholar 

  2. Hamid O et al. N Engl J Med. 2013;369(2):134–44.

    Article  CAS  Google Scholar 

  3. Ferris RL et al. N Engl J Med. 2016;375(19):1856–67.

    Article  Google Scholar 

  4. Yanik EL et al. JAMA Oncol. 2017;3(7):974–78.

    Article  Google Scholar 

  5. Balermpas P et al. Oncoimmunology. 2017;6(3):e1288331.

    Article  Google Scholar 

  6. Tumeh PC et al. Nature. 2014;515(7528):568–71

    Article  CAS  Google Scholar 

  7. Snyder A et al. N Engl J Med. 2014;371(23):2189–99.

    Article  Google Scholar 

  8. Martin D et al. Biochim Biophys Acta. 2017;1868(1):221–30.

    CAS  PubMed  Google Scholar 

  9. Badoual C et al. Cancer Res. 2013;73(1):128–38.

    Article  CAS  Google Scholar 

  10. Liu C et al. Mol Med Rep. 2017;15(3):1063–70.

    Article  Google Scholar 

  11. Partlová S et al. Oncoimmunology. 2015;4(1):e965570.

    Article  Google Scholar 

  12. Sharabi AB et al. Lancet Oncol. 2015;16(13):e498–509.

    Article  Google Scholar 

  13. Erstpubliziert in Strahlenther Onkol. 2017;194(4):356-57.

  14. Morris VK et al. Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): a multicentre, single-arm, phase 2 study. Lancet Oncol. 2017;18(4):446–53.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Strahlentherapie der Universität Frankfurt, Frankfurt, Deutschland

    Daniel Martin,  Claus Rödel &  Emmanouil Fokas

Authors
  1. Daniel Martin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Claus Rödel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Emmanouil Fokas
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Daniel Martin.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Martin, D., Rödel, C. & Fokas, E. Nivolumab für das vorbehandelte metastasierte Analkarzinom. Info Onkol. 21, 30–31 (2018). https://doi.org/10.1007/s15004-018-6094-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15004-018-6094-4

Search

Navigation